In a 12-week randomized phase IIa trial in adults with obesity, the dual GLP-1/GLP-2 receptor agonist dapiglutide was well ...

Researchers at The Hospital for Sick Children (SickKids) , working with international collaborators and youth and family caregivers, have developed a ...

The Trump administration has pledged to conduct its own studies, but research continues to contradict its claims.

Eating unhealthy foods early in life leave lasting brain and feeding changes but gut bacteria can help restore healthy eating, new University College Cork (UCC) research study finds today (Tuesday 24t ...

Taking ashwagandha for up to three months may improve sleep quality and reduce anxiety and stress. However, its long-term safety beyond this period is not well known.

In 2024, the FDA granted 510(k) clearance to a hemodialysis machine capable of delivering online high-volume hemodiafiltration. Since then, companies have started phased introduction of the system ...

Conservation has never lacked ideas. Protected areas, payments for ecosystem services, community management, certification schemes, and public campaigns have all been promoted as solutions to ...

Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by ...

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product candidates for immuno-inflammatory diseases, today announced that it has ...

Blinded, Sham-Controlled Study Designed to be Executed in Collaboration with Lindus Health to Support Future FDA Submission ...

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today ...

BACKGROUND: Novel treatments are needed for the primary and secondary prevention of heart failure in patients with type 2 diabetes, including individuals with and those without a history of heart ...